Rafael S Pinheiro1, Paulo Herman2, Renato M Lupinacci2, Quirino Lai3, Evandro S Mello4, Fabricio F Coelho2, Marcos V Perini2, Vincenzo Pugliese2, Wellington Andraus2, Ivan Cecconello2, Luiz Carneiro D'Albuquerque2. 1. Department of Gastroenterology, University of São Paulo Medical School, Hospital das Clínicas, Rua Dr Enéas de Carvalho Aguiar, 255, 9° Andar-sala 9113/9114, CEP 05403-900, São Paulo, Brazil. Electronic address: rsnpinheiro@gmail.com. 2. Department of Gastroenterology, University of São Paulo Medical School, Hospital das Clínicas, Rua Dr Enéas de Carvalho Aguiar, 255, 9° Andar-sala 9113/9114, CEP 05403-900, São Paulo, Brazil. 3. Department of General Surgery and Organ Transplantation, Sapienza University of Rome, Umberto I Policlinic of Rome, Rome, Italy. 4. Department of Pathology, University of São Paulo Medical School, São Paulo, Brazil.
Abstract
BACKGROUND: Surgical resection is the gold standard therapy for the treatment of colorectal liver metastases (CRM). The aim of this study was to investigate the impact of tumor growth patterns on disease recurrence. METHODS: We enrolled 91 patients who underwent CRM resection. Pathological specimens were prospectively evaluated, with particular attention given to tumor growth patterns (infiltrative vs pushing). RESULTS: Tumor recurrence was observed in 65 patients (71.4%). According to multivariate analysis, 3 or more lesions (P = .05) and the infiltrative tumor margin type (P = .05) were unique independent risk factors for recurrence. Patients with infiltrative margins had a 5-year disease-free survival rate significantly inferior to patients with pushing margins (20.2% vs 40.5%, P = .05). CONCLUSIONS: CRM patients with pushing margins presented superior disease-free survival rates compared with patients with infiltrative margins. Thus, the adoption of the margin pattern can represent a tool for improved selection of patients for adjuvant treatment.
BACKGROUND: Surgical resection is the gold standard therapy for the treatment of colorectal liver metastases (CRM). The aim of this study was to investigate the impact of tumor growth patterns on disease recurrence. METHODS: We enrolled 91 patients who underwent CRM resection. Pathological specimens were prospectively evaluated, with particular attention given to tumor growth patterns (infiltrative vs pushing). RESULTS:Tumor recurrence was observed in 65 patients (71.4%). According to multivariate analysis, 3 or more lesions (P = .05) and the infiltrative tumor margin type (P = .05) were unique independent risk factors for recurrence. Patients with infiltrative margins had a 5-year disease-free survival rate significantly inferior to patients with pushing margins (20.2% vs 40.5%, P = .05). CONCLUSIONS: CRM patients with pushing margins presented superior disease-free survival rates compared with patients with infiltrative margins. Thus, the adoption of the margin pattern can represent a tool for improved selection of patients for adjuvant treatment.
Authors: R L Eefsen; P B Vermeulen; I J Christensen; O D Laerum; M B Mogensen; H C Rolff; G G Van den Eynden; G Høyer-Hansen; K Osterlind; B Vainer; M Illemann Journal: Clin Exp Metastasis Date: 2015-03-31 Impact factor: 5.150
Authors: Kristoffer Watten Brudvik; Yoshihiro Mise; Michael Hsiang Chung; Yun Shin Chun; Scott E Kopetz; Guillaume Passot; Claudius Conrad; Dipen M Maru; Thomas A Aloia; Jean-Nicolas Vauthey Journal: Ann Surg Oncol Date: 2016-03-25 Impact factor: 5.344
Authors: L Viganò; B Branciforte; V Laurenti; G Costa; F Procopio; M Cimino; D Del Fabbro; L Di Tommaso; G Torzilli Journal: Ann Surg Oncol Date: 2022-06-10 Impact factor: 4.339
Authors: E P van der Stok; M Smid; A M Sieuwerts; P B Vermeulen; S Sleijfer; N Ayez; D J Grünhagen; J W M Martens; C Verhoef Journal: Mol Oncol Date: 2016-09-20 Impact factor: 6.603
Authors: Waleed Shady; Elena N Petre; Efsevia Vakiani; Etay Ziv; Mithat Gonen; Karen T Brown; Nancy E Kemeny; Stephen B Solomon; David B Solit; Constantinos T Sofocleous Journal: Oncotarget Date: 2017-08-02
Authors: Pieter-Jan van Dam; Eric P van der Stok; Laure-Anne Teuwen; Gert G Van den Eynden; Martin Illemann; Sophia Frentzas; Ali W Majeed; Rikke L Eefsen; Robert R J Coebergh van den Braak; Anthoula Lazaris; Maria Celia Fernandez; Boris Galjart; Ole Didrik Laerum; Roni Rayes; Dirk J Grünhagen; Michelle Van de Paer; Yves Sucaet; Hardeep Singh Mudhar; Michael Schvimer; Hanna Nyström; Mark Kockx; Nigel C Bird; Fernando Vidal-Vanaclocha; Peter Metrakos; Eve Simoneau; Cornelis Verhoef; Luc Y Dirix; Steven Van Laere; Zu-Hua Gao; Pnina Brodt; Andrew R Reynolds; Peter B Vermeulen Journal: Br J Cancer Date: 2017-10-05 Impact factor: 7.640